These novel therapies, including Wegovy, a similar compound, and Retatrutide , represent a major advancement in addressing type 2 hyperglycemia and assisting with weight management. They function by imitating the body’s natural incretin substance, helping to control blood glucose and decrease appetite . The drug has slightly unique characteristic